YUHS transfer metastatic anticancer drug candidate technology to Repure Life Science
기사승인 2019.05.28 16:28:37
Lee Han-soo corea022@docdocdoc.co.kr
- 1PharmaLilly aims to reshape Korea’s breast cancer treatment market
- 2Special[Special]Korean drugmakers harbor undue expectations on global blockbusters
- 3Device/ICTVuno's dementia diagnosis medical device wins certification
- 4PharmaJapanese pharma companies closely following 'Boycott Japan' campaign
- 5HospitalRheumatoid arthritis treatment can improve Alzheimer symptoms
- 6PharmaWill Gilead enter the autoimmune diseases market?
- 7PharmaSamsung Bioepis readies phase-3 trial on Soliris biosimilar
set_C1
